Home/SixPeaks Bio/Konrad Bleicher

KB

Konrad Bleicher

SVP Therapeutic Modalities

Therapeutic Areas

Obesity Cardiometabolic Diseases

SixPeaks Bio Pipeline

Drug	Indication	Phase
ActRIIA/B Program	Preservation/expansion of skeletal muscle mass as companion to GLP-1 RAs for obesity	Pre-clinical

Leadership Team at SixPeaks Bio

Philip Just Larsen

Chief Executive Officer

Estelle Marrer-Berger

SVP Non-Clinical & Translational Development

Cornelia Maurer

Director Finance

View full SixPeaks Bio profile